DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dimercaptosuccinic acid
Dimercaptosuccinic acid
Review of Succimer for Treatment of Lead Poisoning
WO 2014/195872 Al 11 December 2014 (11.12.2014) P O P C T
Chelating Drug Therapy: an Update
Changes in Tissue Gadolinium Biodistribution Measured in an Animal Model Exposed to Four Chelating Agents
Recommended Chelation Protocol for Children with Blls ≥45 Μg/Dl
Effect of Chromium(VI) on Serum Iron and Removal of Its Toxicity by Combining Deferasirox and Deferiprone Chelators in Rats
AX Pharmaceutical Corp Product List
The Regional Center for Poison Control and Prevention Serving Massachusetts and Rhode Island
Poison Control Antidote Poster
Heavy Metal Chelation and Testing
An Oral Treatment for Lead Toxicity Paul S
Critical Medicines List (PDF 745KB)
Lead Intoxication Treated with D-Penicillamine
Oral Chelation Therapy for Patients with Lead Poisoning
ANTIDOTE CHART ***This Poster Is Not Intended for Individual Patient Care
D-Penicillamine: the State of the Art in Humans and in Dogs from a Pharmacological and Regulatory Perspective
Combined Dimercaptosuccinic Acid and Zinc Treatment in Neurological Wilson’S Disease Patients with Penicillamine-Induced Allergy Or Early Neurological Deterioration
A Review on Coordination Properties of Thiol-Containing Chelating Agents Towards Mercury, Cadmium, and Lead
Top View
Aaseth J., 1995. Treatment of Mercury and Lead Poisonings with Dimercaptosuccinic Acid (DMSA) and Sodium Dimmercapto-Propanesulfonate (DMPS)
Use of Chelating Agents in Medicine
Pediatric Toxicology Specialized Approach to the Poisoned Child
Insufficient Stocking of Antidotes in Hospital Pharmacies: Problem, Causes, and Solution Jean-François Bussières and Benoît Bailey
DMSA Challenge Test for Heavy Metal Poisoning*
China Regulatory and Market Access Pharmaceutical Report 2014
EDTA Chelation Therapy in the Treatment of Toxic Metals Exposure
Chelation in Metal Intoxication
Synergistic Protective Effect of Beta Vulgaris with Meso-2,3
Insights on Alpha Lipoic and Dihydrolipoic Acids As Promising
SPECIFIC ANTIDOTES Administered After Toxicant Absobtion
Chelation Therapy in the Treatment of Metal Intoxication Page Left Intentionally Blank Chelation Therapy in the Treatment of Metal Intoxication
Review Article Rationale for the Successful Management of EDTA Chelation Therapy in Human Burden by Toxic Metals
Official Journal C329 Volume 33 of the European Communities 31 December 1990
(12) Patent Application Publication (10) Pub. No.: US 2016/02877.45 A1 Grinstaff Et Al
Antidotal Effect of Succimer and Cana 2 EDTA on Workers Exposed To
A Case of Drug-Induced Proximal Tubular Dysfunction
Efficacy of Oral DMSA and Intravenous EDTA in Chelation of Toxic Metals and Improvement of the Number of Stem/ Progenitor Cells in Circulation
Mercury Toxicity and Antioxidants: Part I: Role of Glutathione and Alpha-Lipoic Acid in the Treatment of Mercury Toxicity Lyn Patrick, ND
Chelation Therapy in Intoxications with Mercury, Lead and Copper
Pdf 578.32 K
Detoxification of Arsenic and Chromium Through Chelators and Enzymes: an In-Silico Approach
Chelation Therapy Effective Date: 2/1/17
Chelation for Autism Spectrum Disorder (ASD) (Review)
Succimer / 2,3-Dimercaptosuccinic Acid / DMSA
Lead Poisoning Now Arise Either As a Result of Occupational Exposure Or Following the Use of Oral Or Topical Tradi- Tional Remedies And/Or Cosmetics That Contain Lead
Succimer Only Capsule 100 Mg
Advertising (PDF)
Modulatory Role of Chelating Agents in Diet-Induced Hypercholesterolemia in Rats
(Saved As DTPA-FINAL
(DMSA), a Non-Toxic, Water-Soluble Treatment for Heavy Metal Toxicity
Chelation in Metal Intoxication¬タヤprinciples and Paradigms
Removal of Heavy Metals from the Body System by Chelation Therapy
View U.S. Patent Application Publication No. US-2020-0199185 in PDF Format
DRAFT April 2005
NATO HANDBOOK on MEDICAL ASPECTS of NBC DEFENSIVE OPERATIONS Amedp-6(B)
The Selection and Use of Essential Medicines
A Comparative Study of Edetate Calcium Disodium And